Insider · CIK 0002058437

Elmelech Idan

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

Transactions

Companies

Filings

CIK

0002058437

Forms 4 and 5

Insider transactions

3 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment	COO & Principal Financial Ofcr	FTax Payment	−343 sh	$3.94	−$1,351.42	14,152
2026-07-01	BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment	COO & Principal Financial Ofcr	FTax Payment	−343 sh	$7.80	−$2,675.4	14,495
2026-05-10	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	COO & Principal Financial Ofcr	AAward	+758K sh	—	—	758,222

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 256 EAST GRAND AVENUE, SUITE 104

SOUTH SAN FRANCISCO, CA, 94080